Response to Buratti et al.: Can a 'patch' in a skipped exon make the pre-mRNA splicing machine run better?

Trends in Molecular Medicine

Volumn 9, Issue 6, 2003, Pages 233-234

  Eperon, Ian C ^a   Muntoni, Francesco ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; MESSENGER RNA; SERINE;

AMINO ACID SEQUENCE; EXON; FIBROBLAST; GENE; HUMAN; REVIEW; RNA SEQUENCE; RNA SPLICING; SMN2 GENE;

EID: 0038603946     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(03)00068-6     Document Type: Short Survey

References (2)

1. Cartegni, L. and Krainer, A.R. (2003) Correction of disease-associated exon skipping by synthetic exon-specific activators. Nat. Struct. Biol. 10, 120-125
2. Skordis, L.A. et al. (2003) Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 100, 4114-4119